COVID-19 vaccines: in favour of a bespoke compensation scheme for adverse effects. A briefing paper
Files in This Item:
|Briefing Note for CV-19 vaccine acceptability - 28 0ct 20 - final.pdf||223.2 kB||Adobe PDF||Request a copy|
|Title:||COVID-19 vaccines: in favour of a bespoke compensation scheme for adverse effects. A briefing paper||Authors:||Fairgrieve, Duncan; Holm, Søren; Howells, Geraint; Kirchhelle, Claas; Vanderslott, Samantha||Permanent link:||http://hdl.handle.net/10197/11704||Date:||11-Nov-2020||Online since:||2020-11-17T17:21:39Z||Abstract:||This is a briefing paper on behalf of a group of specialists drawn from different disciplines setting out the arguments in favour of a bespoke compensatory scheme for adverse effects to a COVID-19 vaccine(s). As set out below, it is our view that a no-fault compensation scheme could play a valuable role in relation to the acceptability of emergency COVID-19 vaccines.||Funding Details:||Wellcome Trust||Type of material:||Technical Report||Publisher:||British Institute of International and Comparative Law||Keywords:||COVID-19; Coronavirus; Vaccination acceptability; Compensation||Other versions:||https://www.biicl.org/publications/covid-19-vaccines-in-favour-of-a-bespoke-compensation-scheme-for-adverse-effects-a-briefing-paper||Language:||en||Status of Item:||Not peer reviewed|
|Appears in Collections:||History Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.